Uromigos-Paper of the Month

Advertisement
The UromigosThe Uromigos | January 30, 2024
Karim Fizazi, MD, PhD, joins the show to discuss the phase III TALAPRO-2 trial published in Nature.
Listen Now
The UromigosThe Uromigos | January 30, 2024
Dr. Rahul Aggarwal discusses his recent paper on a phase 1/2 study on Lu-177 with pembrolizumab for mCRPC.
The UromigosThe Uromigos | September 14, 2023
Dr. Susan F. Slovin discusses her recent paper that examined abiraterone with and without cabazitaxel for mCRPC.
The UromigosThe Uromigos | January 30, 2024
Dr. Meeks discusses expression-based subtypes for defining pathologic response to neoadjuvant ICIs in patients with MIBC.
The UromigosThe Uromigos | January 30, 2024
Dr. Andrea Necchi describes his recent phase 2 study on the use of neoadjuvant pembrolizumab and nab-paclitaxel for MIBC.
The UromigosThe Uromigos | January 30, 2024
The Uromigos chat with Axel Merseburger about his paper on continuing enzalutamide with docetaxel for the treatment of CRPC.
The UromigosThe Uromigos | January 30, 2024
The Uromigos chat with Cora Sternberg on her paper on FGFR inhibition in advanced urothelial cancer.
The UromigosThe Uromigos | January 30, 2024
John Kelly summarizes a recent paper published in JAMA that describes the benefits of robotic surgery versus open cystectomy.
The UromigosThe Uromigos | January 30, 2024
Alex Wyatt joins The Uromigos to answer questions about ctDNA in prostate cancer and discuss his latest paper on that topic.
The UromigosThe Uromigos | February 17, 2023
Syed Hussain and Sam Funt describe their studies on this topic.
The UromigosThe Uromigos | October 21, 2022
Martin Stockler describes the ENZAMET trial, which shows mixed effects of enza on QOL in prostate cancer.
The UromigosThe Uromigos | August 1, 2023
Yelena Janjigian describes ipi/nivo versus nivo chemo versus chemo in gastric cancer.
The UromigosThe Uromigos | February 7, 2022
Elizabeth de Vries describes her paper on this topic published in Annals of Oncology.
The UromigosThe Uromigos | March 10, 2023
Chad Tang discusses his oncology paper recently published in Lancet.
The UromigosThe Uromigos | November 17, 2021
Dr. Samra Turajlic describes her paper on clear cell renal cell carcinoma.
The UromigosThe Uromigos | October 29, 2021
Dr. Mike Atkins discusses the role of CTLA4 inhibition in RCC.
The UromigosThe Uromigos | October 27, 2021
Dr. Tanya Dorff discusses the TALAPRO-1 study and the role of PARP inhibitors in prostate cancer.
The UromigosThe Uromigos | August 27, 2021
Martin Eklund discusses his papers published in the New England Journal of Medicine and Lancet Oncology.
The UromigosThe Uromigos | May 26, 2021
Dr. Eric Jonasch gives an overview of his paper published in Nature Medicine.
The UromigosThe Uromigos | February 15, 2023
Dr. Petros Grivas discusses the accelerated approval of sacituzumab govitecan in bladder cancer.
Advertisement
Advertisement
Advertisement